Cargando…
A systematic review of cannabidiol dosing in clinical populations
AIMS: Cannabidiol (CBD) is a cannabis‐derived medicinal product with potential application in a wide‐variety of contexts; however, its effective dose in different disease states remains unclear. This review aimed to investigate what doses have been applied in clinical populations, in order to unders...
Autores principales: | Millar, S.A., Stone, N.L., Bellman, Z.D., Yates, A.S., England, T.J., O'Sullivan, S.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710502/ https://www.ncbi.nlm.nih.gov/pubmed/31222854 http://dx.doi.org/10.1111/bcp.14038 |
Ejemplares similares
-
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
por: Millar, Sophie A., et al.
Publicado: (2018) -
A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
por: Sultan, Salahaden R., et al.
Publicado: (2017) -
Warfarin dosing algorithms: A systematic review
por: Asiimwe, Innocent G., et al.
Publicado: (2020) -
Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis
por: Patterson, Richard, et al.
Publicado: (2018) -
High-dose versus low-dose angiotensin converting enzyme inhibitors in heart failure: systematic review and meta-analysis
por: Migliavaca, Celina Borges, et al.
Publicado: (2020)